Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Bioengineering and Biotechnology|July 29, 2020
Discovery of Highly Active Recombinant PNGase H+ Variants Through the Rational Exploration of Unstudied Acidobacterial GenomesRui-Rui Guo, Gerard Comamala, Huan-Huan Yang, et al.
Plos One|July 14, 2012
Low level sequence variant analysis of recombinant proteins: an optimized approachAnne Zeck, Jörg Thomas Regula, Vincent Larraillet, et al.
Annals of Surgical Oncology|February 5, 2017
Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment ProtocolsMarkus W Löffler, Heiko Schuster, Anne Zeck, et al.
Journal of the American Society for Mass Spectrometry|September 27, 2023
Development of a PNGase Rc Column for Online Deglycosylation of Complex Glycoproteins during HDX-MSThomas Lambert, Marius Gramlich, Luisa Stutzke, et al.
ACS Applied Materials & Interfaces|November 11, 2021
Altered Proinflammatory Responses to Polyelectrolyte Multilayer Coatings Are Associated with Differences in Protein Adsorption and WettabilityFlorian Billing, Bernadette Walter, Simon Fink, et al.
Frontiers in Immunology|December 27, 2021
Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4+ CellsBjoern Traenkle, Philipp D Kaiser, Stefania Pezzana, et al.
EMBO Reports|April 27, 2021
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodiesTeresa R Wagner, Elena Ostertag, Philipp D Kaiser, et al.
Frontiers in Immunology|January 2, 2024
Two birds with one stone: human SIRPα nanobodies for functional modulation and in vivo imaging of myeloid cellsTeresa R Wagner, Simone Blaess, Inga B Leske, et al.
Nature Communications|February 20, 2021
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivityMatthias Becker, Monika Strengert, Daniel Junker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron VariantsDaniel Junker, Matthias Becker, Teresa R Wagner, et al.
Pageof 3